Time-resolved fluorescence methods have been used to show that 8-hydroxy-1,3,6-pyrenetrisulfonate (HPT), a fluorescent analog of 2,3-diphosphoglycerate, binds to the central cavity of carboxyhemoglobin A (HbACO) at pH 6.35. A direct quantitative approach, based on the distinctive free and bound HPT fluorescent lifetimes of 5.6 ns and ϳ27 ps, respectively, was developed to measure the binding affinity of this probe. HPT binds to a single site and is displaced by inositol hexaphosphate at a 1:1 mol ratio, indicating that binding occurs at the 2,3-diphosphoglycerate site in the central cavity. Furthermore, the results imply that low pH HbACO exists as an altered R state and not an equilibrium mixture of R and T states. The probe was also used to monitor competitive effector binding and to compare the affinity of the binding site in several cross-bridged HbA derivatives.The solvent-accessible central cavity of hemoglobin A (HbA) 1 contains functionally important binding sites for several classes of allosteric effectors that facilitate the lowering of oxygen affinity (1, 2). The -subunit end of the central cavity contains a cluster of eight positive charges that interact with the negative charges of 2,3-diphosphoglycerate (DPG) (3). This site also binds a variety of other negatively charged effectors such as inositol hexaphosphate (IHP), inorganic phosphate, chloride, and polyglutamic acid. The other end (␣-subunit) of the central cavity contains additional binding sites, particularly for chloride ions. Another class of potent effectors derived from clofibric acid and bezafibrate (e.g. L35) bind near the middle of the central cavity with their negative charges projecting toward the ␣-subunit end (4 -6). Binding of these effectors is also associated with a reduction in oxygen affinity. Study of these effectors is of practical interest since control of oxygen affinity is a necessary component for the design of acellular Hb-based oxygen carriers (7, 8).X-ray crystallographic studies are important both in pinpointing effector-binding sites and in characterizing the geometry of the effector-bound site (2). However, other methods must be used to determine the structural and functional interactions that are important in solution and to perform titration studies for obtaining binding constants as a function of solution conditions and/or structural state. Functionally relevant synergistic and antagonistic effects among effectors are also best elucidated through solution studies. Functional characterization of hemoglobin suggests that synergistic and competitive activity can occur when combinations of effectors are bound (4). Of the various allosteric effectors, the interactions of DPG (the natural allosteric effector found in the red blood cell) and its analogs in HbA have been investigated the most extensively. However, the binding of DPG can only be measured indirectly through its effects on ligand reactivity and on spectroscopically accessible chromophores such as the heme groups. In this report, we present an extension o...